Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tetra-specific, octameric binding agents and antibodies against Clostridium difficile toxin A and toxin B for treatment of C. difficile infection

Tetra-specific, octameric binding agents and antibodies against Clostridium difficile toxin A and toxin B for treatment of C. difficile infection

US Patent 10961299 · Granted Mar 30, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Text-to-speech synthesis method, electronic device, and computer-readable storag2025
Yeast-based immunotherapy against Clostridium difficile infection2025
Speech synthesis method, device and computer-readable storage medium2025
Method for generating a talking head video with mouth movement sequence, device 2025
Protein inhibitors of clostridium difficile toxin b2024
Protein inhibitors of clostridium difficile toxin b2024
Hot extrusion die and hot extrusion integral forming method for special-shaped s2024
Methods, compositions and kits for treating a subject using a recombinant hetero2024
Humanized tetra-specific octavalent antibody against clostridium difficile toxin2024
Humanized tetra-specific octavalent antibody against clostridium difficile toxin2024
Humanized tetra-specific octavalent antibody against clostridium difficile toxin2024
Array substrate and method for manufacturing the same, display panel2024